Tartu, Estonia

Olev Kahre

This inventor holds 6 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Solis Biodyne Ou. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olev Kahre. Retrieved from https://idiyas.com/inventor/olev-kahre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Tartu, EP (2016)
  • Tartu, EE (2017 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Olev Kahre: Innovator Enhancing Polypeptide Stability and Activity

Introduction:

Olev Kahre, a talented inventor based in Tartu, EE, has made significant contributions to the field of polypeptide stability and reverse transcription methods. With a strong background in biotechnology and molecular biology, Kahre has been awarded four patents and has been associated with companies like Solis Biodyne OÜ. Let us explore Kahre's latest patents, notable career highlights, and collaborations in more detail.

Latest Patents:

Kahre's recent patents reveal his innovative approaches in enhancing polypeptide stability and activity, as well as optimizing reverse transcription processes. His groundbreaking patents include:

1. "Compositions for Increasing Polypeptide Stability and Activity, and Related Methods":

This patent focuses on developing peptides, polypeptides, and fusion polypeptides that are linked to a peptide tag. These tag-linked polypeptides are designed to augment the stability of polypeptides, such as Taq polymerase. Kahre's compositions and methods also have the potential to enhance the activity, specificity, and fidelity of other polypeptides in a reaction mixture.

2. "Synthetic Reverse Transcriptases and Uses Thereof":

This patent introduces non-natural reverse transcriptases, specifically designed for conducting reverse transcription. These novel reverse transcriptases possess enhanced thermostability and exhibit higher efficiency than their natural counterparts. Kahre's invention opens up possibilities for more efficient reverse transcription processes in various applications.

Career Highlights:

Throughout his career, Olev Kahre has showcased his expertise in the field of biotechnology and molecular biology. His notable career highlights include:

- Years of experience working at Solis Biodyne OÜ, a renowned biotechnology company involved in developing advanced molecular biology tools.

- Application of his knowledge in polypeptide stability and reverse transcription methodologies to make groundbreaking advancements in the field.

- Demonstrated leadership qualities and problem-solving capabilities in his role as an inventor and researcher.

Collaborations:

Kahre has enjoyed working alongside talented individuals who share his passion for scientific exploration. Some notable colleagues include:

- Kadri Artma: Known for her expertise in molecular biology, Artma has collaborated with Kahre on projects related to optimizing reverse transcription methods.

- Tiina Kahre: As a fellow researcher, Tiina Kahre has worked closely with Olev Kahre to develop innovative solutions for enhancing polypeptide stability and activity.

Conclusion:

Olev Kahre's contributions to the field of biotechnology and molecular biology, particularly in the areas of polypeptide stability and reverse transcription, have been instrumental in advancing scientific understanding and practical applications. His inventive patents and collaborations highlight his commitment to innovation and progress. With ongoing developments and discoveries, it is evident that Olev Kahre will continue to leave a lasting impact on the field of molecular biology and biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…